Table 1.

Clinical characteristics of COVID-19 patients according to disease severity

	Total N = 134	Severe N = 19	Non-severe N = 115	P value
Age, median (IQR), y	33.0 (21.8–46.3)	53.0 (37.0–61.0)	30.0 (20.0–42.0)	< 0.001
Sex, male n (%)	69 (51.5%)	11 (57.9%)	58 (50.4%)	0.547
Exposure history within past 14 days, n (%)
Living in Hubei	41 (30.6%)	8 (42.1%)	33 (28.7%)	0.007
Recently visited Hubei	32 (23.9%)	4 (21.1%)	28 (24.3%)
Contact with people from Hubei	27 (20.1%)	7 (36.8%)	20 (17.4%)
Contact with other confirmed patients	34 (25.4%)	0	34 (29.6%)
Cluster cases, n (%)	72 (53.7%)	11 (57.9%)	61 (53.0%)	0.694
Comorbidities, n (%)
Any	25 (18.7%)	12 (63.2%)	13 (11.3%)	< 0.001
Diabetes	10 (7.5%)	6 (31.6%)	4 (3.5%)	< 0.001
Hypertension	14 (10.4%)	7 (36.8%)	7 (6.1%)	< 0.001
Coronary heart disease	1 (0.7%)	1 (5.3%)	0	0.142
Chronic bronchitis	1 (0.7%)	1 (5.3%)	0	0.142
Gout	2 (1.5%)	1 (5.3%)	1 (0.9%)	0.264
Cancer	1 (0.7%)	0	1 (0.9%)	> 0.99
AIDS	1 (0.7%)	0	1 (0.9%)	> 0.99
Thyroid disease	2 (1.5%)	2 (10.5%)	0	0.019

Bold values indicate that P value is less than 0.05

COVID-19 coronavirus disease 2019, IQR interquartile range, AIDS acquired immune deficiency syndrome